Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis

Table 1 Glycemic outcomes in each of the studies that are chosen for assessing eligibility for meta-analysis

Ref.	Type of study							HbA1c	FBG	C-peptide levels	PBG	Insulin requirements
	Randomized	Non-randomized	Blindness	Prospective	Retrospective	Parallel	Cross over
Cai et al[12]1	+		NB	+		+		+	+	+		+
Packham et al[13]1	+		DB	+		+		+
Carlsson et al[14]1	+		NB	+		+		+		+		+
Leão et al[15]1		+	NB		+	+		+
Skyler et al[16]1	+		SB	+		+			+	+
Thakkar et al[17]1		+	NB	+		+		+	+	+	+	+
Zhao et al[18]1	+		NB	+		+		+		+
Wu et al[19]1	+		NB	+		+		+	+	+		+
Wu et al[20]1	+		NB	+		+		+	+	+		+
Vanikar et al[21]2		+	NB	+		+		+	+	+	+	+
Bhansali et al[22]2	+		SB	+		+		+	+	+		+
Hu et al[23]2	+		SB	+		+		+	+	+		+
Hu et al[24]2	+		DB	+		+		+	+	+	+	+
Jiang et al[25]2		+	NB	+				+	+	+		+
Li et al[26]2		+	NB	+				+	+	+	+	+
Lian et al[27]2		+	NB	+				+	+	+	+	+
Liu et al[28]2		+	NB	+		+		+	+	+	+	+
Moon et al[29]2	+		SB	+		+		+	+		+
Nguyen et al[30]2	+		NB	+		+		+	+	+		+
De Guzman et al[31]2		+	NB	+				+	+			+
Guan et al[32]2		+	NB	+				+	+	+
Purwati et al[33]2		+	NB	+				+	+	+		+

¹Studies that have undergone meta-analysis.

²Studies that have not undergone meta-analysis.

HbA1c: Hemoglobin A1c; FBG: Fasting blood glucose; PBG: Postprandial blood glucose; DB: Double blind; NB: Not blinded; SB: Single blinded.